Insider · CIK 0001638945

Thye Dirk

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001638945

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-23	IRLAIRulya Therapeutics Inc. · Employee Stock Option (Right to Buy)A Award	Director, CEO and CMO	AAward	+1M sh	—	—	1,000,000
2025-12-10	IRLAIRulya Therapeutics Inc.G Gift	Director, CEO and CMO	GGift	−740K sh	—	—	255,000
2025-12-10	IRLAIRulya Therapeutics Inc.G Gift	Director, CEO and CMO	GGift	+740K sh	—	—	739,885
2025-06-18	IRLAIRulya Therapeutics Inc.A Award	Director, CEO and CMO	AAward	+151K sh	$1.20	+$181K	994,885
2025-06-18	IRLAIRulya Therapeutics Inc. · WarrantsA Award	Director, CEO and CMO	AAward	+151K sh	$0.13	+$18.9K	150,944
2025-01-28	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and CMO	AAward	+1.2M sh	—	—	1,200,000
2024-08-30	IRLAIRulya Therapeutics Inc.P Purchase	Director, CEO and CMO	PPurchase	+77K sh	$0.70	+$53.9K	843,941
2024-08-29	IRLAIRulya Therapeutics Inc.P Purchase	Director, CEO and CMO	PPurchase	+77.5K sh	$0.69	+$53.5K	766,941
2024-02-01	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and CMO	AAward	+1.5M sh	—	—	1,500,000
2024-01-16	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Director, CEO and CMO	MExercise/Conversion	+90.5K sh	$0.55	+$49.8K	539,442
2024-01-16	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Director, CEO and CMO	MExercise/Conversion	+150K sh	$0.94	+$141K	689,441
2024-01-16	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CEO and CMO	MExercise/Conversion	−90.5K sh	—	—	115,860
2024-01-16	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CEO and CMO	MExercise/Conversion	−150K sh	—	—	450,001
2023-08-10	IRLAIRulya Therapeutics Inc.P Purchase	Director, CEO and CMO	PPurchase	+88K sh	$1.26	+$111K	448,911
2023-08-08	IRLAIRulya Therapeutics Inc.P Purchase	Director, CEO and CMO	PPurchase	+80K sh	$1.24	+$99.2K	360,911
2023-02-01	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and CMO	AAward	+600K sh	—	—	600,000
2022-05-23	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and CMO	AAward	+1.98M sh	—	—	1,979,650
2022-05-19	IRLAIRulya Therapeutics Inc.A Award	Director, CEO and CMO	AAward	+64.6K sh	—	—	64,589
2022-05-19	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and CMO	AAward	+206K sh	—	—	206,391
2022-05-19	IRLAIRulya Therapeutics Inc.A Award	Director, CEO and CMO	AAward	+216K sh	—	—	280,911
2016-03-16	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+80K sh	—	—	80,000

Recent filings

Accepted (ET)
Jan 234
Thye Dirk0000912282-26-000121
SEC(opens sec.gov)
Dec 124
Thye Dirk0000912282-25-001407
SEC(opens sec.gov)
Jun 234
Thye Dirk0000912282-25-000695
SEC(opens sec.gov)
Feb 114
Thye Dirk0001415889-25-003618
SEC(opens sec.gov)
Sep 34
Thye Dirk0001415889-24-022702
SEC(opens sec.gov)
Feb 24
Thye Dirk0001415889-24-002378
SEC(opens sec.gov)
Jan 174
Thye Dirk0001415889-24-001313
SEC(opens sec.gov)
Aug 114
Thye Dirk0001209191-23-045432
SEC(opens sec.gov)
Aug 94
Thye Dirk0001209191-23-045235
SEC(opens sec.gov)
Feb 24
Thye Dirk0001209191-23-006402
SEC(opens sec.gov)
May 274/A
Thye Dirk0001209191-22-032675
SEC(opens sec.gov)
May 234
Thye Dirk0001209191-22-031515
SEC(opens sec.gov)

Companies

Address

C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 273

SOUTH SAN FRANCISCO, CA, 94080